[
    {
        "text": "(bright music begins)",
        "start": 0.97,
        "duration": 3.167
    },
    {
        "text": "I'm very excited to give this talk",
        "start": 8.53,
        "duration": 3.09
    },
    {
        "text": "to such a broad audience of speakers",
        "start": 11.62,
        "duration": 4.1
    },
    {
        "text": "and people who have zoomed into this symposium.",
        "start": 15.72,
        "duration": 5.0
    },
    {
        "text": "I wanted to start by thanking Chemical and Engineering News",
        "start": 20.9,
        "duration": 3.21
    },
    {
        "text": "for organizing this symposium,",
        "start": 24.11,
        "duration": 1.61
    },
    {
        "text": "and I'm very honored to have been selected",
        "start": 25.72,
        "duration": 3.13
    },
    {
        "text": "as part of the class of 2021.",
        "start": 28.85,
        "duration": 1.863
    },
    {
        "text": "So with that,",
        "start": 32.34,
        "duration": 1.8
    },
    {
        "text": "I wanted to focus this presentation on",
        "start": 34.14,
        "duration": 3.36
    },
    {
        "text": "sharing some of the boarder interest in my lab",
        "start": 39.85,
        "duration": 4.54
    },
    {
        "text": "where we try to address some different questions",
        "start": 47.02,
        "duration": 3.09
    },
    {
        "text": "in immunology and neuroinflammation",
        "start": 50.11,
        "duration": 1.81
    },
    {
        "text": "by the application of chemical proteomic approaches.",
        "start": 51.92,
        "duration": 3.01
    },
    {
        "text": "But before I go into more science,",
        "start": 54.93,
        "duration": 3.66
    },
    {
        "text": "I wanted to start by also describing",
        "start": 58.59,
        "duration": 2.94
    },
    {
        "text": "my journey to the Rockefeller University.",
        "start": 61.53,
        "duration": 2.81
    },
    {
        "text": "So I was born and raised in Moscow, Russia,",
        "start": 64.34,
        "duration": 2.99
    },
    {
        "text": "where my parents did a fantastic job",
        "start": 67.33,
        "duration": 2.09
    },
    {
        "text": "raising me and my sister by taking us out",
        "start": 69.42,
        "duration": 3.99
    },
    {
        "text": "to dacha every summer where we could go",
        "start": 73.41,
        "duration": 2.53
    },
    {
        "text": "and grow vegetables and go mushroom picking.",
        "start": 75.94,
        "duration": 3.55
    },
    {
        "text": "But by also focusing on making sure",
        "start": 79.49,
        "duration": 3.02
    },
    {
        "text": "that we learned English very early on,",
        "start": 82.51,
        "duration": 2.05
    },
    {
        "text": "which is a very useful skill as I've learned over the years,",
        "start": 84.56,
        "duration": 4.66
    },
    {
        "text": "as well as my mom played a big role by being very proactive",
        "start": 89.22,
        "duration": 5.0
    },
    {
        "text": "with seeking out opportunities for both me and my sister",
        "start": 94.82,
        "duration": 4.1
    },
    {
        "text": "in terms of our education.",
        "start": 98.92,
        "duration": 2.39
    },
    {
        "text": "And she was the reason why I attended a high school",
        "start": 101.31,
        "duration": 4.71
    },
    {
        "text": "that was focusing on chemistry, actually very early on,",
        "start": 106.02,
        "duration": 3.48
    },
    {
        "text": "and started doing research very early on",
        "start": 109.5,
        "duration": 3.71
    },
    {
        "text": "in like conjugate chemistry and polysaccharide analytics.",
        "start": 113.21,
        "duration": 3.413
    },
    {
        "text": "After high school, I went on to do my MSc studies",
        "start": 118.4,
        "duration": 4.83
    },
    {
        "text": "in higher chemical college of Russian Academy of Sciences,",
        "start": 123.23,
        "duration": 4.05
    },
    {
        "text": "but there were a number of people who have influenced",
        "start": 127.28,
        "duration": 3.29
    },
    {
        "text": "and shaped my scientific interests during that time,",
        "start": 130.57,
        "duration": 4.29
    },
    {
        "text": "as I've gone on a number of internships around the world,",
        "start": 134.86,
        "duration": 2.98
    },
    {
        "text": "including United States, Switzerland, and France.",
        "start": 137.84,
        "duration": 5.0
    },
    {
        "text": "And I'm very grateful for all the mentors that I've met",
        "start": 143.01,
        "duration": 4.28
    },
    {
        "text": "throughout these experiences,",
        "start": 147.29,
        "duration": 1.68
    },
    {
        "text": "both working on my master thesis with Yulia",
        "start": 148.97,
        "duration": 3.21
    },
    {
        "text": "but also going to do research internships around the globe.",
        "start": 152.18,
        "duration": 5.0
    },
    {
        "text": "And if you pay more attention to the list of the names,",
        "start": 157.509,
        "duration": 4.101
    },
    {
        "text": "you will recognize a theme emerging.",
        "start": 161.61,
        "duration": 2.95
    },
    {
        "text": "I was very attracted to organometallic chemistry",
        "start": 164.56,
        "duration": 2.46
    },
    {
        "text": "back in the days,",
        "start": 167.02,
        "duration": 1.51
    },
    {
        "text": "and it was not a surprise for my family",
        "start": 168.53,
        "duration": 4.15
    },
    {
        "text": "when I decided to go to MIT to pursue my PhD studies,",
        "start": 172.68,
        "duration": 3.783
    },
    {
        "text": "or with Steve Buchwald,",
        "start": 177.61,
        "duration": 1.973
    },
    {
        "text": "doing research in organometallic chemistry,",
        "start": 180.64,
        "duration": 2.54
    },
    {
        "text": "and mostly working on applying",
        "start": 183.18,
        "duration": 3.665
    },
    {
        "text": "organometallic chemistry approaches",
        "start": 186.845,
        "duration": 1.945
    },
    {
        "text": "to expand our synthetic toolbox,",
        "start": 188.79,
        "duration": 4.01
    },
    {
        "text": "but also in the very end of my PhD studies,",
        "start": 192.8,
        "duration": 3.18
    },
    {
        "text": "applying organometallic chemistry",
        "start": 195.98,
        "duration": 1.65
    },
    {
        "text": "to chemical biology and bioconjugation in collaboration,",
        "start": 197.63,
        "duration": 3.47
    },
    {
        "text": "with Brad Pentelute's lab.",
        "start": 201.1,
        "duration": 3.68
    },
    {
        "text": "Following my PhD studies,",
        "start": 204.78,
        "duration": 1.23
    },
    {
        "text": "I moved across the country",
        "start": 206.01,
        "duration": 1.2
    },
    {
        "text": "to pursue my post-doctoral work with Ben Cravatt,",
        "start": 207.21,
        "duration": 3.193
    },
    {
        "text": "where I really took a deeper dive",
        "start": 212.523,
        "duration": 3.463
    },
    {
        "text": "into chemical biology and chemical proteomics,",
        "start": 215.986,
        "duration": 3.264
    },
    {
        "text": "and worked in collaboration with",
        "start": 219.25,
        "duration": 2.52
    },
    {
        "text": "a number of very talented people,",
        "start": 221.77,
        "duration": 1.91
    },
    {
        "text": "but in particular,",
        "start": 223.68,
        "duration": 0.9
    },
    {
        "text": "John Teijaro, who we collaborated on our project",
        "start": 224.58,
        "duration": 3.89
    },
    {
        "text": "on studying T cells and applying",
        "start": 228.47,
        "duration": 4.28
    },
    {
        "text": "chemical proteomics platforms to understand",
        "start": 232.75,
        "duration": 3.05
    },
    {
        "text": "T cell misregulation.",
        "start": 235.8,
        "duration": 2.05
    },
    {
        "text": "So, as Beth mentioned,",
        "start": 237.85,
        "duration": 1.63
    },
    {
        "text": "I'm currently an assistant professor",
        "start": 239.48,
        "duration": 3.01
    },
    {
        "text": "and head of the lab of chemical immunology and proteomics",
        "start": 242.49,
        "duration": 2.75
    },
    {
        "text": "at Rockefeller University,",
        "start": 245.24,
        "duration": 1.28
    },
    {
        "text": "and our lab was very recently established in December, 2020.",
        "start": 246.52,
        "duration": 3.673
    },
    {
        "text": "So our overarching goal in the lab is expanding",
        "start": 251.55,
        "duration": 4.38
    },
    {
        "text": "our understanding of misregulation of protein function",
        "start": 255.93,
        "duration": 3.65
    },
    {
        "text": "in disease,",
        "start": 259.58,
        "duration": 0.833
    },
    {
        "text": "and coming up with new methods",
        "start": 260.413,
        "duration": 2.027
    },
    {
        "text": "for targeting protein function in disease.",
        "start": 262.44,
        "duration": 2.73
    },
    {
        "text": "And we tried to do it",
        "start": 265.17,
        "duration": 1.88
    },
    {
        "text": "in the context of trying to study",
        "start": 267.05,
        "duration": 4.55
    },
    {
        "text": "the state-dependent chemical immunology and neuroimmunology,",
        "start": 271.6,
        "duration": 3.78
    },
    {
        "text": "and we do this through the development",
        "start": 275.38,
        "duration": 1.45
    },
    {
        "text": "of new chemical tools,",
        "start": 276.83,
        "duration": 1.72
    },
    {
        "text": "which will help us",
        "start": 278.55,
        "duration": 2.45
    },
    {
        "text": "to block the protein function",
        "start": 281.0,
        "duration": 3.97
    },
    {
        "text": "through targeting active sites",
        "start": 284.97,
        "duration": 1.69
    },
    {
        "text": "of proteins or protein degradation,",
        "start": 286.66,
        "duration": 2.42
    },
    {
        "text": "as well as through the advancement of proteomic platforms.",
        "start": 289.08,
        "duration": 4.34
    },
    {
        "text": "And I will tell you a little bit more throughout",
        "start": 293.42,
        "duration": 2.39
    },
    {
        "text": "the talk about this.",
        "start": 295.81,
        "duration": 2.1
    },
    {
        "text": "So why are we interested in studying",
        "start": 297.91,
        "duration": 2.23
    },
    {
        "text": "misregulated immune responses?",
        "start": 300.14,
        "duration": 2.06
    },
    {
        "text": "I guess it won't be an understatement",
        "start": 302.2,
        "duration": 2.13
    },
    {
        "text": "that the past two years have really highlighted",
        "start": 304.33,
        "duration": 2.35
    },
    {
        "text": "the role of our immune system",
        "start": 306.68,
        "duration": 1.53
    },
    {
        "text": "as a guardian against pathogens,",
        "start": 308.21,
        "duration": 2.138
    },
    {
        "text": "as well as cancer.",
        "start": 310.348,
        "duration": 1.812
    },
    {
        "text": "But when misregulated immune system",
        "start": 312.16,
        "duration": 1.96
    },
    {
        "text": "plays a number of deleterious roles,",
        "start": 314.12,
        "duration": 2.43
    },
    {
        "text": "including playing a causal role",
        "start": 316.55,
        "duration": 3.59
    },
    {
        "text": "for a number of different diseases,",
        "start": 320.14,
        "duration": 2.25
    },
    {
        "text": "ranging from auto immune diseases",
        "start": 322.39,
        "duration": 2.94
    },
    {
        "text": "to neurodegeneration and cancer,",
        "start": 325.33,
        "duration": 2.81
    },
    {
        "text": "and it is greatly appreciated that immune cells",
        "start": 328.14,
        "duration": 3.22
    },
    {
        "text": "can undergo a number of phenotypic changes,",
        "start": 331.36,
        "duration": 2.17
    },
    {
        "text": "which makes them big players in both",
        "start": 333.53,
        "duration": 3.21
    },
    {
        "text": "human physiology and pathology.",
        "start": 336.74,
        "duration": 2.63
    },
    {
        "text": "And over the years,",
        "start": 339.37,
        "duration": 1.47
    },
    {
        "text": "a number of global scale genomic and transcriptomic",
        "start": 340.84,
        "duration": 3.22
    },
    {
        "text": "approaches have emerged to try to understand these changes",
        "start": 344.06,
        "duration": 4.467
    },
    {
        "text": "on a more molecular level,",
        "start": 349.45,
        "duration": 1.63
    },
    {
        "text": "and oftentimes generating unique signatures",
        "start": 351.08,
        "duration": 4.78
    },
    {
        "text": "for misregulated self states",
        "start": 355.86,
        "duration": 2.11
    },
    {
        "text": "in specific pathologic conditions,",
        "start": 357.97,
        "duration": 2.953
    },
    {
        "text": "which lead to identification of a number",
        "start": 361.81,
        "duration": 2.1
    },
    {
        "text": "of not just misregulated genes,",
        "start": 363.91,
        "duration": 4.54
    },
    {
        "text": "but also proteins that change in expression",
        "start": 368.45,
        "duration": 3.61
    },
    {
        "text": "under different pathologic states.",
        "start": 372.06,
        "duration": 2.77
    },
    {
        "text": "However,",
        "start": 374.83,
        "duration": 0.833
    },
    {
        "text": "it is very important to know that molecular events",
        "start": 375.663,
        "duration": 2.707
    },
    {
        "text": "that lead to functional changes",
        "start": 378.37,
        "duration": 2.25
    },
    {
        "text": "often don't involve changes in gene or protein abundance,",
        "start": 380.62,
        "duration": 3.18
    },
    {
        "text": "and therefore methods for gaining a better molecular level",
        "start": 383.8,
        "duration": 4.95
    },
    {
        "text": "understanding of these post-translational changes",
        "start": 388.75,
        "duration": 3.47
    },
    {
        "text": "are very important.",
        "start": 392.22,
        "duration": 1.933
    },
    {
        "text": "So, as I already mentioned,",
        "start": 395.31,
        "duration": 1.77
    },
    {
        "text": "immune cells undergo a number of phenotypic changes.",
        "start": 397.08,
        "duration": 2.83
    },
    {
        "text": "And a lot of times the phenotypic changes",
        "start": 399.91,
        "duration": 2.18
    },
    {
        "text": "are associated with biochemical changes,",
        "start": 402.09,
        "duration": 2.3
    },
    {
        "text": "and these have been studied extensively over the years,",
        "start": 404.39,
        "duration": 3.75
    },
    {
        "text": "and a number of these changes don't really also go in hand",
        "start": 408.14,
        "duration": 4.687
    },
    {
        "text": "with the gene expression changes",
        "start": 413.84,
        "duration": 2.71
    },
    {
        "text": "and require additional methods for studying them.",
        "start": 416.55,
        "duration": 3.73
    },
    {
        "text": "And furthermore,",
        "start": 420.28,
        "duration": 2.14
    },
    {
        "text": "how these biochemical changes correspond",
        "start": 422.42,
        "duration": 2.75
    },
    {
        "text": "to molecular level changes,",
        "start": 425.17,
        "duration": 1.37
    },
    {
        "text": "as I already mentioned,",
        "start": 426.54,
        "duration": 2.12
    },
    {
        "text": "is poorly understood,",
        "start": 428.66,
        "duration": 1.69
    },
    {
        "text": "and our lab wants to develop platforms",
        "start": 430.35,
        "duration": 4.23
    },
    {
        "text": "to be able to assess these molecular level changes,",
        "start": 434.58,
        "duration": 3.87
    },
    {
        "text": "to gain new insights into biology,",
        "start": 438.45,
        "duration": 3.4
    },
    {
        "text": "but also to identify new targets",
        "start": 441.85,
        "duration": 2.72
    },
    {
        "text": "that can be specifically targeted in itself.",
        "start": 444.57,
        "duration": 4.753
    },
    {
        "text": "So basically the question that we are asking in the lab",
        "start": 451.906,
        "duration": 2.504
    },
    {
        "text": "and that I started asking when I was a postdoc",
        "start": 454.41,
        "duration": 2.13
    },
    {
        "text": "in Ben Cravatt's group,",
        "start": 456.54,
        "duration": 0.95
    },
    {
        "text": "is can we use these nucleophilic amino acid residues,",
        "start": 457.49,
        "duration": 3.38
    },
    {
        "text": "such as cysteine and lysine,",
        "start": 460.87,
        "duration": 1.76
    },
    {
        "text": "as sensors of these biochemical changes",
        "start": 462.63,
        "duration": 2.2
    },
    {
        "text": "during immune cell misregulation or activation, or both.",
        "start": 464.83,
        "duration": 3.793
    },
    {
        "text": "And indeed, cysteine has been used as a handle",
        "start": 470.21,
        "duration": 2.88
    },
    {
        "text": "for protein structure determination,",
        "start": 473.09,
        "duration": 2.11
    },
    {
        "text": "back in the 1960s,",
        "start": 475.2,
        "duration": 1.25
    },
    {
        "text": "where Kendrew and Perutz used organomercury complexes",
        "start": 476.45,
        "duration": 5.0
    },
    {
        "text": "to facilitate x-ray structure determination,",
        "start": 481.81,
        "duration": 2.98
    },
    {
        "text": "for which they got their Nobel prize for.",
        "start": 484.79,
        "duration": 4.2
    },
    {
        "text": "Furthermore, cysteine and lysine were used",
        "start": 488.99,
        "duration": 2.0
    },
    {
        "text": "as handles to study protein dynamics",
        "start": 490.99,
        "duration": 2.3
    },
    {
        "text": "also back 10 to 20 years ago,",
        "start": 493.29,
        "duration": 5.0
    },
    {
        "text": "by a number of very accomplished scientists,",
        "start": 498.61,
        "duration": 4.76
    },
    {
        "text": "three of the Nobel laureates are listed below,",
        "start": 503.37,
        "duration": 3.67
    },
    {
        "text": "who have contributed to the studies",
        "start": 507.04,
        "duration": 1.85
    },
    {
        "text": "of using cysteine and lysine as handles",
        "start": 508.89,
        "duration": 2.12
    },
    {
        "text": "to study protein dynamics to NMR methodologies.",
        "start": 511.01,
        "duration": 4.64
    },
    {
        "text": "However, these approaches,",
        "start": 515.65,
        "duration": 0.993
    },
    {
        "text": "while very powerful to study",
        "start": 516.643,
        "duration": 2.497
    },
    {
        "text": "protein structures and protein dynamics,",
        "start": 519.14,
        "duration": 2.21
    },
    {
        "text": "only focus on specific proteins in isolated settings.",
        "start": 521.35,
        "duration": 5.0
    },
    {
        "text": "So what we are trying to ask",
        "start": 526.76,
        "duration": 1.64
    },
    {
        "text": "and what we're trying to achieve is",
        "start": 528.4,
        "duration": 1.81
    },
    {
        "text": "we're trying to apply these broad scale proteomic platforms",
        "start": 530.21,
        "duration": 4.46
    },
    {
        "text": "to gain very similar structural and functional insights",
        "start": 534.67,
        "duration": 3.832
    },
    {
        "text": "into the biochemistry of proteins",
        "start": 538.502,
        "duration": 3.068
    },
    {
        "text": "that is changing depending on the cell states.",
        "start": 541.57,
        "duration": 2.55
    },
    {
        "text": "And there are a number of chemical proteomic platforms",
        "start": 544.12,
        "duration": 2.03
    },
    {
        "text": "that have been developed over the past,",
        "start": 546.15,
        "duration": 2.983
    },
    {
        "text": "through the pioneering work of",
        "start": 550.06,
        "duration": 1.6
    },
    {
        "text": "Ben Carvatt and D'Ambrosio as well.",
        "start": 551.66,
        "duration": 2.04
    },
    {
        "text": "And the more recent work coming out of their labs",
        "start": 553.7,
        "duration": 2.89
    },
    {
        "text": "and other labs within the proteomic community.",
        "start": 556.59,
        "duration": 4.31
    },
    {
        "text": "But these days,",
        "start": 560.9,
        "duration": 0.97
    },
    {
        "text": "we are able to ask these broad scale questions",
        "start": 561.87,
        "duration": 3.72
    },
    {
        "text": "where we're looking into, for example,",
        "start": 565.59,
        "duration": 2.42
    },
    {
        "text": "drug ability on a protium wide-scale",
        "start": 568.01,
        "duration": 2.13
    },
    {
        "text": "so which sites can across the proteome",
        "start": 570.14,
        "duration": 3.51
    },
    {
        "text": "can accommodate ligands for drug development purposes,",
        "start": 573.65,
        "duration": 3.9
    },
    {
        "text": "but also what we call reactivity profiling,",
        "start": 577.55,
        "duration": 4.22
    },
    {
        "text": "where we are looking at the differences",
        "start": 581.77,
        "duration": 3.23
    },
    {
        "text": "in the innate reactivity of specific cysteine residues",
        "start": 585.0,
        "duration": 3.75
    },
    {
        "text": "in different cell states,",
        "start": 588.75,
        "duration": 1.23
    },
    {
        "text": "and we're trying to use them as a potential opportunity",
        "start": 589.98,
        "duration": 5.0
    },
    {
        "text": "to target pathological but not physiological states.",
        "start": 595.35,
        "duration": 2.98
    },
    {
        "text": "And just a little bit in more detail,",
        "start": 598.33,
        "duration": 1.78
    },
    {
        "text": "when we're using the reactivity profiling platforms,",
        "start": 600.11,
        "duration": 4.18
    },
    {
        "text": "we're looking at the reactivity of specific sites",
        "start": 604.29,
        "duration": 2.297
    },
    {
        "text": "and proteins in cells and different states.",
        "start": 606.587,
        "duration": 3.013
    },
    {
        "text": "And we're looking at the differential relativity",
        "start": 609.6,
        "duration": 3.07
    },
    {
        "text": "with the broadly reactive iota sediment probes,",
        "start": 612.67,
        "duration": 4.19
    },
    {
        "text": "or either probes for lysine targeting.",
        "start": 616.86,
        "duration": 4.12
    },
    {
        "text": "And we're hoping to use this as an unbiased tool",
        "start": 620.98,
        "duration": 2.62
    },
    {
        "text": "for discovery of biochemical changes in cells.",
        "start": 623.6,
        "duration": 3.94
    },
    {
        "text": "And indeed, we were able to highlight this",
        "start": 627.54,
        "duration": 1.84
    },
    {
        "text": "in the case of T-cell activation,",
        "start": 629.38,
        "duration": 1.743
    },
    {
        "text": "where a number of proteins showed",
        "start": 633.538,
        "duration": 1.792
    },
    {
        "text": "increased reactivity of specific cysteines",
        "start": 635.33,
        "duration": 2.19
    },
    {
        "text": "involved in redox regulation,",
        "start": 637.52,
        "duration": 1.47
    },
    {
        "text": "likely reflecting on a higher reducing potential",
        "start": 638.99,
        "duration": 2.41
    },
    {
        "text": "of activated T cells.",
        "start": 641.4,
        "duration": 1.88
    },
    {
        "text": "And I just wanted to also show this example",
        "start": 643.28,
        "duration": 2.28
    },
    {
        "text": "where we're finding sites that are changing in reactivity",
        "start": 645.56,
        "duration": 2.84
    },
    {
        "text": "that are close to cofactor or metabolite binding sites,",
        "start": 648.4,
        "duration": 4.18
    },
    {
        "text": "serving as kind of handouts to read out",
        "start": 652.58,
        "duration": 3.34
    },
    {
        "text": "the biochemical changes within the cells.",
        "start": 655.92,
        "duration": 2.99
    },
    {
        "text": "So as I already mentioned,",
        "start": 658.91,
        "duration": 1.61
    },
    {
        "text": "another approach that we're using is this so-called",
        "start": 660.52,
        "duration": 3.32
    },
    {
        "text": "druggability or ligandability profiling approach,",
        "start": 663.84,
        "duration": 2.66
    },
    {
        "text": "which allows us,",
        "start": 666.5,
        "duration": 0.87
    },
    {
        "text": "through the use of so-called small molecule scout fragments,",
        "start": 667.37,
        "duration": 4.004
    },
    {
        "text": "to interrogate the whole protium",
        "start": 671.374,
        "duration": 3.086
    },
    {
        "text": "on the ability of specific residues",
        "start": 674.46,
        "duration": 2.43
    },
    {
        "text": "to accommodate the cysteine electrophiles",
        "start": 676.89,
        "duration": 4.03
    },
    {
        "text": "for future drug development purposes.",
        "start": 680.92,
        "duration": 2.34
    },
    {
        "text": "And indeed the carbene electrophiles possess",
        "start": 683.26,
        "duration": 2.26
    },
    {
        "text": "a number of benefits for drug development purposes.",
        "start": 685.52,
        "duration": 3.93
    },
    {
        "text": "And this approach allows us to read out",
        "start": 689.45,
        "duration": 4.09
    },
    {
        "text": "the thousands of sites in a single proteomic experiment.",
        "start": 693.54,
        "duration": 4.15
    },
    {
        "text": "And we applied this approach to studying T cell activation",
        "start": 697.69,
        "duration": 3.38
    },
    {
        "text": "and identified over 3000 sites that can, in theory,",
        "start": 701.07,
        "duration": 2.78
    },
    {
        "text": "be targeted with small molecule covalent electrophiles,",
        "start": 703.85,
        "duration": 3.45
    },
    {
        "text": "including sites on the proteins,",
        "start": 707.3,
        "duration": 2.16
    },
    {
        "text": "which are typically considered harder to drug proteins,",
        "start": 709.46,
        "duration": 2.59
    },
    {
        "text": "such as adaptor proteins and transcription factors.",
        "start": 712.05,
        "duration": 3.93
    },
    {
        "text": "And I'm also showing you one target",
        "start": 715.98,
        "duration": 1.95
    },
    {
        "text": "that highlights the importance of applying these methods",
        "start": 717.93,
        "duration": 4.39
    },
    {
        "text": "to different cells and different cell states,",
        "start": 722.32,
        "duration": 2.65
    },
    {
        "text": "because we also identified a number of sites",
        "start": 724.97,
        "duration": 4.5
    },
    {
        "text": "that can be targeted with",
        "start": 729.47,
        "duration": 0.91
    },
    {
        "text": "small molecule covalent electrophiles",
        "start": 730.38,
        "duration": 1.77
    },
    {
        "text": "in checkpoint receptors,",
        "start": 732.15,
        "duration": 1.21
    },
    {
        "text": "which were only quantified in the activated T cells",
        "start": 733.36,
        "duration": 4.1
    },
    {
        "text": "versus the quiescent G cells.",
        "start": 737.46,
        "duration": 1.933
    },
    {
        "text": "So what do we do to advance these ligands",
        "start": 740.56,
        "duration": 4.36
    },
    {
        "text": "to more elaborated probes?",
        "start": 744.92,
        "duration": 2.61
    },
    {
        "text": "We usually try to come up with function first approach",
        "start": 747.53,
        "duration": 4.1
    },
    {
        "text": "as to be able to screen more advanced libraries",
        "start": 751.63,
        "duration": 3.27
    },
    {
        "text": "of compounds with covalent electrophilic warheads.",
        "start": 754.9,
        "duration": 4.43
    },
    {
        "text": "And one of the approaches is shown here",
        "start": 759.33,
        "duration": 1.54
    },
    {
        "text": "where we use the assay for inhibitors of T cell activation.",
        "start": 760.87,
        "duration": 5.0
    },
    {
        "text": "And we realized that this approach allows us",
        "start": 766.18,
        "duration": 4.35
    },
    {
        "text": "to identify ligands with unique pharmacology,",
        "start": 770.53,
        "duration": 3.83
    },
    {
        "text": "where three out of the four compounds",
        "start": 774.36,
        "duration": 1.8
    },
    {
        "text": "that we were following up on",
        "start": 776.16,
        "duration": 2.38
    },
    {
        "text": "showed their mechanism of action to involve degradation",
        "start": 778.54,
        "duration": 3.95
    },
    {
        "text": "of their respective targets from different protein classes.",
        "start": 782.49,
        "duration": 3.1
    },
    {
        "text": "And most interestingly,",
        "start": 785.59,
        "duration": 1.84
    },
    {
        "text": "the degradation of the proteins",
        "start": 787.43,
        "duration": 1.53
    },
    {
        "text": "was actually a state-dependent,",
        "start": 788.96,
        "duration": 2.28
    },
    {
        "text": "then a very good example of it is this ITK degrader",
        "start": 791.24,
        "duration": 3.96
    },
    {
        "text": "that I'll briefly go in this story.",
        "start": 795.2,
        "duration": 5.0
    },
    {
        "text": "So we're interested in this series",
        "start": 800.57,
        "duration": 3.37
    },
    {
        "text": "of stereoisomeric probes",
        "start": 803.94,
        "duration": 2.01
    },
    {
        "text": "that we started studying them in collaboration",
        "start": 805.95,
        "duration": 3.49
    },
    {
        "text": "with professor Schreiber's lab.",
        "start": 809.44,
        "duration": 3.08
    },
    {
        "text": "And the reason why we are interested in it is",
        "start": 812.52,
        "duration": 1.95
    },
    {
        "text": "because having sets of these stereoisomeric probes",
        "start": 814.47,
        "duration": 3.36
    },
    {
        "text": "allows us to streamline the mechanism of action studies,",
        "start": 817.83,
        "duration": 4.18
    },
    {
        "text": "as well as target focus studies for understanding the roles",
        "start": 822.01,
        "duration": 4.15
    },
    {
        "text": "of specific targets as they provide both",
        "start": 826.16,
        "duration": 4.53
    },
    {
        "text": "in structured activity relationship",
        "start": 830.69,
        "duration": 2.67
    },
    {
        "text": "within the library design.",
        "start": 833.36,
        "duration": 2.41
    },
    {
        "text": "So indeed we found a set of four compounds",
        "start": 835.77,
        "duration": 2.31
    },
    {
        "text": "where only one compound,",
        "start": 838.08,
        "duration": 1.8
    },
    {
        "text": "only one stereoisomer showed inhibition of T cell activation",
        "start": 839.88,
        "duration": 5.0
    },
    {
        "text": "and looking at the targets of the compounds,",
        "start": 845.03,
        "duration": 2.27
    },
    {
        "text": "we were able to identify a limited set of targets",
        "start": 847.3,
        "duration": 2.88
    },
    {
        "text": "that were specific for the active compound,",
        "start": 850.18,
        "duration": 4.59
    },
    {
        "text": "but I wanted to just highlight that we also believe",
        "start": 854.77,
        "duration": 3.37
    },
    {
        "text": "that being able to do chemical proteomic profiling",
        "start": 858.14,
        "duration": 2.87
    },
    {
        "text": "on these stereoisomers also allows us to pick up",
        "start": 861.01,
        "duration": 2.71
    },
    {
        "text": "compounds that specifically target",
        "start": 865.07,
        "duration": 2.68
    },
    {
        "text": "their protein targets",
        "start": 871.15,
        "duration": 1.7
    },
    {
        "text": "in a stereoselective manner,",
        "start": 872.85,
        "duration": 1.37
    },
    {
        "text": "which allows us to start in additional programs",
        "start": 874.22,
        "duration": 3.57
    },
    {
        "text": "into looking into the function of those proteins",
        "start": 877.79,
        "duration": 2.2
    },
    {
        "text": "and the inhibition of those sites.",
        "start": 879.99,
        "duration": 2.72
    },
    {
        "text": "So going back to the targets of the active compounds,",
        "start": 882.71,
        "duration": 3.52
    },
    {
        "text": "we also identified ITK and other immune relevant kinase",
        "start": 886.23,
        "duration": 5.0
    },
    {
        "text": "to be another target of these compounds.",
        "start": 892.91,
        "duration": 2.3
    },
    {
        "text": "But in this case,",
        "start": 895.21,
        "duration": 1.61
    },
    {
        "text": "we didn't see this site to be engaged of ITK",
        "start": 896.82,
        "duration": 3.41
    },
    {
        "text": "because we don't see this peptide",
        "start": 900.23,
        "duration": 1.27
    },
    {
        "text": "in our proteomics experiments,",
        "start": 901.5,
        "duration": 1.62
    },
    {
        "text": "but we saw state dependent degradation of ITK",
        "start": 903.12,
        "duration": 3.1
    },
    {
        "text": "in our whole protium and enrich proteomics experiments.",
        "start": 906.22,
        "duration": 2.91
    },
    {
        "text": "And here I'm just showing you",
        "start": 909.13,
        "duration": 1.2
    },
    {
        "text": "the stereoselective degradation of ITK.",
        "start": 910.33,
        "duration": 3.17
    },
    {
        "text": "And what's very interesting to us",
        "start": 913.5,
        "duration": 2.52
    },
    {
        "text": "is that the more studies we do,",
        "start": 916.02,
        "duration": 2.7
    },
    {
        "text": "and the more compounds that we uncover",
        "start": 918.72,
        "duration": 2.13
    },
    {
        "text": "to be small molecule degraders of protein targets,",
        "start": 920.85,
        "duration": 3.7
    },
    {
        "text": "is the more we understand",
        "start": 924.55,
        "duration": 2.02
    },
    {
        "text": "that the ligand does matter for protein degradation.",
        "start": 926.57,
        "duration": 2.88
    },
    {
        "text": "So by comparing our compound",
        "start": 929.45,
        "duration": 2.19
    },
    {
        "text": "to the known inhibitor of cysteine 422 and ITK kinase,",
        "start": 931.64,
        "duration": 3.87
    },
    {
        "text": "we're able to see that while the known inhibitor",
        "start": 935.51,
        "duration": 3.3
    },
    {
        "text": "actually stabilizes the inactive confirmation of ITK,",
        "start": 938.81,
        "duration": 3.43
    },
    {
        "text": "our inhibitor leads to ITK degradation,",
        "start": 942.24,
        "duration": 4.18
    },
    {
        "text": "although the known inhibitor does prevent our compound",
        "start": 946.42,
        "duration": 4.37
    },
    {
        "text": "from T cell activation induced degradation.",
        "start": 950.79,
        "duration": 5.0
    },
    {
        "text": "So finding these examples",
        "start": 957.71,
        "duration": 4.22
    },
    {
        "text": "from our T cell focus study",
        "start": 961.93,
        "duration": 3.35
    },
    {
        "text": "has really highlighted the fact that",
        "start": 965.28,
        "duration": 2.24
    },
    {
        "text": "the small molecule covalent electrophiles",
        "start": 967.52,
        "duration": 1.75
    },
    {
        "text": "can serve as privileged scaffolds for protein degradation.",
        "start": 969.27,
        "duration": 3.59
    },
    {
        "text": "And we are focusing on building out additional screens",
        "start": 972.86,
        "duration": 4.87
    },
    {
        "text": "to identify new scaffolds",
        "start": 977.73,
        "duration": 2.68
    },
    {
        "text": "that can degrade the protein targets",
        "start": 980.41,
        "duration": 3.19
    },
    {
        "text": "through molecular glue degrader mechanism,",
        "start": 984.6,
        "duration": 2.17
    },
    {
        "text": "but also through other mechanisms.",
        "start": 986.77,
        "duration": 1.92
    },
    {
        "text": "And as are the labs,",
        "start": 988.69,
        "duration": 0.92
    },
    {
        "text": "we're also trying to expand this approach",
        "start": 989.61,
        "duration": 4.96
    },
    {
        "text": "to building out the PROTACs",
        "start": 996.4,
        "duration": 1.91
    },
    {
        "text": "which would basically transform our ligands",
        "start": 998.31,
        "duration": 4.06
    },
    {
        "text": "that we're discovering for specific targets",
        "start": 1002.37,
        "duration": 1.927
    },
    {
        "text": "into potential drug leads",
        "start": 1004.297,
        "duration": 2.843
    },
    {
        "text": "with a functional output through protein degradation.",
        "start": 1007.14,
        "duration": 3.093
    },
    {
        "text": "With that I just wanted to thank Ben",
        "start": 1011.44,
        "duration": 2.32
    },
    {
        "text": "for being an amazing mentor over the years,",
        "start": 1013.76,
        "duration": 2.13
    },
    {
        "text": "and for assembling a fantastic group of people in his lab",
        "start": 1015.89,
        "duration": 3.31
    },
    {
        "text": "who have been helpful throughout my time in Ben's lab.",
        "start": 1020.07,
        "duration": 4.33
    },
    {
        "text": "And I also wanted to thank my new group",
        "start": 1024.4,
        "duration": 3.82
    },
    {
        "text": "at Rockefeller University,",
        "start": 1028.22,
        "duration": 1.14
    },
    {
        "text": "who have been excited about the projects in the lab",
        "start": 1029.36,
        "duration": 5.0
    },
    {
        "text": "and who are very enthusiastic about the science that we do.",
        "start": 1034.56,
        "duration": 5.0
    },
    {
        "text": "I also wanted to thank the funding agencies",
        "start": 1039.73,
        "duration": 2.47
    },
    {
        "text": "and also in particular Rockefeller University,",
        "start": 1042.2,
        "duration": 2.89
    },
    {
        "text": "whose community has been very supportive",
        "start": 1045.09,
        "duration": 2.85
    },
    {
        "text": "while I was starting during the COVID times in 2020.",
        "start": 1047.94,
        "duration": 4.5
    },
    {
        "text": "And just to give",
        "start": 1052.44,
        "duration": 1.25
    },
    {
        "text": "faces to names,",
        "start": 1056.38,
        "duration": 1.06
    },
    {
        "text": "I just wanted to show our current group members in the lab",
        "start": 1057.44,
        "duration": 3.95
    },
    {
        "text": "and just give a small pitch",
        "start": 1061.39,
        "duration": 1.44
    },
    {
        "text": "that we do have positions open for postdoctoral fellows",
        "start": 1062.83,
        "duration": 3.79
    },
    {
        "text": "with cell biology and molecular neuroscience experience",
        "start": 1066.62,
        "duration": 2.82
    },
    {
        "text": "right now in the lab,",
        "start": 1069.44,
        "duration": 1.61
    },
    {
        "text": "so feel free to apply to me directly.",
        "start": 1071.05,
        "duration": 2.66
    },
    {
        "text": "And with that,",
        "start": 1073.71,
        "duration": 0.833
    },
    {
        "text": "I just wanted to thank you for your attention,",
        "start": 1074.543,
        "duration": 1.937
    },
    {
        "text": "and I'm happy to answer any questions.",
        "start": 1076.48,
        "duration": 2.203
    },
    {
        "text": "Thank you so much, Katya.",
        "start": 1080.12,
        "duration": 1.57
    },
    {
        "text": "I'm going to ask one quick question from Dong-Sik Park",
        "start": 1081.69,
        "duration": 2.92
    },
    {
        "text": "who points out there's a lot of files in the cell",
        "start": 1084.61,
        "duration": 4.13
    },
    {
        "text": "and asks basically,",
        "start": 1090.541,
        "duration": 0.833
    },
    {
        "text": "how do you avoid other file containing groups",
        "start": 1091.374,
        "duration": 2.616
    },
    {
        "text": "to get site specificity?",
        "start": 1093.99,
        "duration": 1.2
    },
    {
        "text": "So I think there are a number of good examples",
        "start": 1097.93,
        "duration": 2.76
    },
    {
        "text": "for the development of advanced drugs",
        "start": 1100.69,
        "duration": 4.46
    },
    {
        "text": "that are specific for their respective targets,",
        "start": 1105.15,
        "duration": 5.0
    },
    {
        "text": "including, you know, ibrutinib and acalabrutinib,",
        "start": 1110.17,
        "duration": 3.04
    },
    {
        "text": "so it is a combination of affinity and reactivity",
        "start": 1113.21,
        "duration": 4.076
    },
    {
        "text": "for the cysteine sites.",
        "start": 1117.286,
        "duration": 2.474
    },
    {
        "text": "And another good example is, you know, dimethyl fumarate",
        "start": 1119.76,
        "duration": 3.2
    },
    {
        "text": "which is an approved drug as well",
        "start": 1122.96,
        "duration": 1.73
    },
    {
        "text": "which targets specific cysteines in proteins.",
        "start": 1124.69,
        "duration": 4.293
    },
    {
        "text": "Thanks so much.",
        "start": 1130.08,
        "duration": 1.247
    },
    {
        "text": "(bright music fades out)",
        "start": 1131.327,
        "duration": 3.417
    }
]